BeOne Medicines Ltd.
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302170% above fair value
$355.00−6.27 (-1.74%)
Close on Nov 3, 2026Market cap $40.36BP/E 63.5Yield –
BeOne Medicines Accumulated Amortization by Year
Accumulated Amortization — Developed Technology Rights ($M) ($M)
BeOne Medicines Accumulated Amortization: $15.3M in FY2025, up 23.4% from a year earlier.
Latest, FY2025
15.3
Period ended Dec 31, 2025
Change on a year earlier
+23.4%
12.4 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Intangible Assets Note (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Accumulated Amortization — Developed Technology Rights ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15.3 | +23.4% | Form 10-Q (filed 2026-08-05) ↗ |
| FY2024 | Dec 31, 2024 | 12.4 | +59.0% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 7.80 | +90.2% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 4.10 | +310.0% | Form 10-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 1 | – | Form 10-K (filed 2023-02-27) ↗ |
| FY2020 | Dec 31, 2020 | 0 | – | Form 10-K (filed 2022-02-28) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Accumulated Amortization ($M), annual FY2020–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/intang-accum-tech
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.
See a number that looks wrong?